What is the recommended treatment for a yeast infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Yeast Infection

For uncomplicated Candida vulvovaginitis, either topical antifungal agents or a single 150-mg oral dose of fluconazole is recommended as first-line treatment. 1

Treatment Options Based on Infection Type

Uncomplicated Vulvovaginal Candidiasis (90% of cases)

  • Topical antifungal options (all equally effective) 1:

    • Clotrimazole 1% cream 5g intravaginally for 7-14 days 1
    • Clotrimazole 100mg vaginal tablet for 7 days 1
    • Clotrimazole 100mg vaginal tablet, two tablets for 3 days 1
    • Clotrimazole 500mg vaginal tablet, single application 1
    • Miconazole 2% cream 5g intravaginally for 7 days 1
    • Miconazole 200mg vaginal suppository, one suppository for 3 days 1
    • Miconazole 100mg vaginal suppository, one suppository for 7 days 1
    • Tioconazole 6.5% ointment 5g intravaginally in a single application 1
    • Terconazole 0.4% cream 5g intravaginally for 7 days 1
    • Terconazole 0.8% cream 5g intravaginally for 3 days 1
    • Terconazole 80mg suppository, one suppository for 3 days 1
  • Oral option:

    • Fluconazole 150mg single oral dose 1

Severe Acute Vulvovaginal Candidiasis

  • Fluconazole 150mg, given every 72 hours for a total of 2 or 3 doses 1

Non-albicans Candida Species (C. glabrata)

  • For C. glabrata infections unresponsive to oral azoles:
    • Boric acid 600mg in gelatin capsule, intravaginally daily for 14 days 1
    • Nystatin intravaginal suppositories, 100,000 units daily for 14 days 1
    • Topical 17% flucytosine cream alone or with 3% AmB cream daily for 14 days 1

Recurrent Vulvovaginal Candidiasis

  • Initial treatment: 10-14 days of induction therapy with topical agent or oral fluconazole 1
  • Maintenance: Fluconazole 150mg weekly for 6 months 1

Treatment Algorithm

  1. Determine type of infection:

    • Uncomplicated (90% of cases): Typical symptoms with C. albicans in healthy host 1
    • Complicated (10% of cases): Severe symptoms, non-albicans species, abnormal host, or recurrent infection 1
  2. For uncomplicated infection:

    • Choose either topical antifungal for 1-7 days OR single oral fluconazole 150mg 1
    • Patient preference may guide choice - topicals provide faster symptomatic relief but oral treatment is more convenient 1
  3. For severe infection:

    • Use fluconazole 150mg every 72 hours for 2-3 doses 1
  4. For non-albicans species:

    • Try boric acid 600mg intravaginally daily for 14 days 1
  5. For recurrent infections:

    • Initial intensive treatment followed by maintenance therapy with fluconazole 150mg weekly for 6 months 1

Important Clinical Considerations

  • Diagnosis should be confirmed with wet mount preparation using saline and 10% potassium hydroxide to demonstrate yeast or hyphae 1
  • Vaginal pH is typically normal (<4.5) in Candida infections 1
  • Self-diagnosis of yeast infections is often inaccurate - patients with persistent symptoms despite OTC treatment should seek medical care 1
  • Approximately 10-20% of women normally harbor Candida species in the vagina without symptoms - treatment is not indicated without symptoms 1
  • For denture-related oral candidiasis, disinfection of the denture in addition to antifungal therapy is recommended 1
  • Pregnant women should avoid fluconazole in the first trimester 1

Treatment Efficacy and Follow-up

  • Treatment with azoles results in relief of symptoms and negative cultures in 80-90% of patients 1
  • Single-dose treatments should be reserved for mild-to-moderate uncomplicated cases 1
  • Multi-day regimens (3 and 7-day) are preferred for severe or complicated infections 1
  • Patients should be advised to complete the full course of treatment even if symptoms resolve earlier 2
  • Recurrence within 2 months after treatment warrants medical evaluation 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Topical therapy for fungal infections.

American journal of clinical dermatology, 2004

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.